Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Bases de datos
País/Región como asunto
Tipo del documento
Intervalo de año de publicación
1.
MMWR Morb Mortal Wkly Rep ; 68(29): 642-646, 2019 Jul 26.
Artículo en Inglés | MEDLINE | ID: mdl-31344023

RESUMEN

The number of wild poliovirus (WPV) cases in Nigeria decreased from 1,122 in 2006 to six WPV type 1 (WPV1) in 2014 (1). During August 2014-July 2016, no WPV cases were detected; during August-September 2016, four cases were reported in Borno State. An insurgency in northeastern Nigeria had resulted in 468,800 children aged <5 years deprived of health services in Borno by 2016. Military activities in mid-2016 freed isolated families to travel to camps, where the four WPV1 cases were detected. Oral poliovirus vaccine (OPV) campaigns were intensified during August 2016-December 2017; since October 2016, no WPV has been detected (2). Vaccination activities in insurgent-held areas are conducted by security forces; however, 60,000 unvaccinated children remain in unreached settlements. Since 2018, circulating vaccine-derived poliovirus type 2 (cVDPV2) has emerged and spread from Nigeria to Niger and Cameroon; outbreak responses to date have not interrupted transmission. This report describes progress in Nigeria polio eradication activities during January 2018-May 2019 and updates the previous report (2). Interruption of cVDPV2 transmission in Nigeria will need increased efforts to improve campaign quality and include insurgent-held areas. Progress in surveillance and immunization activities will continue to be reviewed, potentially allowing certification of interruption of WPV transmission in Africa in 2020.


Asunto(s)
Erradicación de la Enfermedad , Brotes de Enfermedades/prevención & control , Poliomielitis/prevención & control , Vigilancia de la Población , Adolescente , Niño , Preescolar , Brotes de Enfermedades/estadística & datos numéricos , Humanos , Programas de Inmunización , Lactante , Nigeria/epidemiología , Poliomielitis/epidemiología , Poliovirus/genética , Poliovirus/aislamiento & purificación , Vacunas contra Poliovirus/administración & dosificación , Evaluación de Programas y Proyectos de Salud , Serogrupo , Violencia
2.
MMWR Morb Mortal Wkly Rep ; 67(8): 253-256, 2018 Mar 02.
Artículo en Inglés | MEDLINE | ID: mdl-29494568

RESUMEN

Nearly three decades after the World Health Assembly launched the Global Polio Eradication Initiative in 1988, four of the six World Health Organization (WHO) regions have been certified polio-free (1). Nigeria is one of three countries, including Pakistan and Afghanistan, where wild poliovirus (WPV) transmission has never been interrupted. In September 2015, after >1 year without any reported WPV cases, Nigeria was removed from WHO's list of countries with endemic WPV transmission (2); however, during August and September 2016, four type 1 WPV (WPV1) cases were reported from Borno State, a state in northeastern Nigeria experiencing a violent insurgency (3). The Nigerian government, in collaboration with partners, launched a large-scale coordinated response to the outbreak (3). This report describes progress in polio eradication activities in Nigeria during January-December 2017 and updates previous reports (3-5). No WPV cases have been reported in Nigeria since September 2016; the latest case had onset of paralysis on August 21, 2016 (3). However, polio surveillance has not been feasible in insurgent-controlled areas of Borno State. Implementation of new strategies has helped mitigate the challenges of reaching and vaccinating children living in security-compromised areas, and other strategies are planned. Despite these initiatives, however, approximately 130,000-210,000 (28%-45%) of the estimated 469,000 eligible children living in inaccessible areas in 2016 have not been vaccinated. Sustained efforts to optimize surveillance and improve immunization coverage, especially among children in inaccessible areas, are needed.


Asunto(s)
Erradicación de la Enfermedad , Poliomielitis/prevención & control , Vacunas contra Poliovirus/administración & dosificación , Vigilancia de la Población , Adolescente , Niño , Preescolar , Humanos , Programas de Inmunización , Lactante , Nigeria/epidemiología , Poliomielitis/epidemiología , Poliovirus/aislamiento & purificación , Vacunas contra Poliovirus/efectos adversos , Medidas de Seguridad
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA